Guardian Pharmacy Services Gross Profit

The latest gross profit for GRDN is $320M as of June 2026. That compares with $260M in the prior-year period — up 21.5% year over year. That is below the sector sector average of $760M. Investors often review this figure alongside Guardian Pharmacy Services's historical trend and sector peers before judging valuation or financial health.

Over the past year, GRDN's gross profit moved from $260M to $320M — a 21.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Guardian Pharmacy Services's operating scale or balance-sheet position.

Against its sector companies, GRDN currently prints $320M for gross profit, while the sector average sits near $760M. That is roughly 58.4% below the sector mean. Large gaps often invite a closer look at Guardian Pharmacy Services's growth, margins, and balance sheet.

A gross profit figure of $320M for GRDN is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $760M. Explore the charts below for those layers of context.

After noting GRDN's gross profit ($320M), review year-over-year change from $260M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.